24 results
S-1/A
EX-10.3
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
”) and its subsidiaries toward even higher achievement and business results, to tie their goals and interests to those of the Company and its … and authority to administer and interpret the Incentive Plan.
Bonus Determinations
(a) Corporate Performance Goals. A Covered Executive may receive
S-1/A
EX-10.2
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
to the attainment of performance goals may become vested and exercisable or nonforfeitable in connection with a Sale Event in the Administrator’s … performance goals and objectives.
(b) Rights as a Stockholder. Upon the grant of the Restricted Stock Award and payment of any applicable purchase price
DEF 14A
CADL
Candel Therapeutics Inc
2 Sep 22
Definitive proxy
8:30am
. The compensation committee’s responsibilities include:
annually reviewing and recommending to the board of directors the corporate goals … goals and objectives and based on such evaluation, recommending to the board of directors the cash compensation of our Chief Executive Officer
S-1/A
CADL
Candel Therapeutics Inc
16 Jul 21
IPO registration (amended)
6:07am
to ensure timely reviews of applications for medical products during the COVID-19 pandemic in line with its user fee performance goals and conducting mission … 2013 through 2021, was unable to reach required goals, thereby triggering the legislation’s automatic reduction to several government programs
S-1
re6l0v 8hx
25 Jun 21
IPO registration
5:28pm
DRS/A
xc316ofgg7ij5ad
31 Mar 21
Draft registration statement (amended)
12:00am
424B4
b58v u4ih
28 Jul 21
Prospectus supplement with pricing info
4:02pm
S-1/A
EX-10.5.2
ocm237
16 Jul 21
IPO registration (amended)
6:07am
10-K
eauy5oyo5gnskk9
29 Mar 22
Annual report
8:46am
10-Q
2t2qph8d841
8 Sep 21
Quarterly report
8:37am